Synchrotron Radiation to the Treatment of Intracranial Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Brain Cancer
Related studies linked through entity extraction aliases.
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
- Status
- COMPLETED
- Phase
- NA
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
- Status
- COMPLETED
- Phase
- NA
Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
- Status
- WITHDRAWN
- Phase
- PHASE2
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
18-F-Fluoroacetate as PET Imaging Agent
- Status
- WITHDRAWN
- Phase
- PHASE1
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
- Status
- TERMINATED
- Phase
- PHASE1
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TPI 287 in Patients With Recurrent Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE2
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
- Status
- TERMINATED
- Phase
- PHASE1
Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
- Status
- TERMINATED
- Phase
- N/A